High-grade transformation of acinic cell carcinoma: an inadequately treated entity?

详细信息    查看全文

• 作者：Ashish V. Chintakuntlawar ; MBBS ; PhD^a ; Wonwoo Shon ; DO^b ; Michele Erickson-Johnson ; PhD^c ; Elizabeth Bilodeau ; DMD ; MD^d ; Sarah M. Jenkins ; MS^e ; Jennifer A. Davidson ; PA^f ; Michael G. Keeney ; MD^f ; Michael Rivera ; MD^f ; Daniel L. Price ; MD^g ; Eric J. Moore ; MD^g ; Kerry D. Olsen ; MD^g ; Jan L. Kasperbauer ; MD^g ; Robert L. Foote ; MD^h ; Katharine A. Price ; MD^a ; ^{price.katharine@mayo.edu" class="auth_mail" title="E-mail the corresponding author} ; Joaquí ; n J. Garcí ; a ; MD^f
• 刊名：Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology
• 出版年：2016
• 出版时间：May 2016
• 年：2016
• 卷：121
• 期：5
• 页码：542-549.e1
• 全文大小：1068 K

文摘

Acinic cell carcinoma (AcCC) is an uncommon salivary gland malignancy. We aim to characterize the clinical and pathologic characteristics of AcCC with and without high-grade transformation (HGT). Importantly, cases of mammary analogue secretory carcinoma, a recently described histologic mimic of AcCC, have been excluded by using cytogenetics and molecular studies.

Study Design

Archival surgical pathology material was obtained for patients diagnosed with AcCC at Mayo Clinic Rochester between 1990 and 2010. Tumors harboring the ETV6-NTRK3 fusion transcript were excluded from analysis by using cytogenetics and molecular studies. Tumors with HGT were characterized by areas with an infiltrative growth pattern, nuclear anaplasia, prominent nucleoli, brisk mitotic activity, geographic necrosis, and stromal desmoplasia. Demographic and clinical data were extracted from the medical records.

Results

AcCC with HGT was seen in 8 of 48 cases (17%). Patients with AcCC with HGT were significantly older than patients without HGT (median 69 vs 54 years; P = .04). Angiolymphatic invasion was more common in AcCC with HGT (P = .02). Relapse-free survival and overall survival were significantly worse for cases of AcCC with HGT (hazard ratio 10.4 and 9.3, respectively; P < .0001 for both comparisons). Locoregional recurrence-free survival was not significantly different (P = .12), but distant metastases-free survival was significantly worse in patients with HGT compared with non-HGT patients (P < .0001).

Conclusions

Prognosis for overall survival and distant relapse for AcCC patients with HGT is significantly worse than that for patients without HGT.